Cargando…

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

BACKGROUND: Conestat alfa (ConA), a recombinant human C1 inhibitor, may prevent thromboinflammation. METHODS: We conducted a randomized, open-label, multi-national clinical trial in which hospitalized adults at risk for progression to severe COVID-19 were assigned in a 2:1 ratio to receive either 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urwyler, Pascal, Leimbacher, Marina, Charitos, Panteleimon, Moser, Stephan, Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Thoma, Reto, Sumer, Johannes, Camacho-Ortiz, Adrián, Bacci, Marcelo R., Huber, Lars C., Stüssi-Helbling, Melina, Albrich, Werner C., Sendi, Parham, Osthoff, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641758/ https://www.ncbi.nlm.nih.gov/pubmed/37965347 http://dx.doi.org/10.3389/fimmu.2023.1255292

Ejemplares similares

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
por: Urwyler, Pascal, et al.
Publicado: (2021)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
por: Urwyler, Pascal, et al.
Publicado: (2020)

Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
por: Urwyler, Pascal, et al.
Publicado: (2022)

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study
por: Charitos, Panteleimon, et al.
Publicado: (2021)

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study
por: Bruni, Flavio, et al.
Publicado: (2022)

Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients
por: Bock, Merete, et al.
Publicado: (2015)

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
por: Osthoff, Michael, et al.
Publicado: (2019)

Impact of Mannose-Binding Lectin Deficiency on Radiocontrast-Induced Renal Dysfunction
por: Osthoff, Michael, et al.
Publicado: (2013)

Neutrophile-to-Lymphocyte Ratio (NLR) Identifies Patients with Coronavirus Infectious Disease 2019 (COVID-19) at High Risk for Deterioration and Mortality—A Retrospective, Monocentric Cohort Study
por: Rose, Jutta, et al.
Publicado: (2022)

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
por: Panagiotou, Anneza, et al.
Publicado: (2018)

A Trial of Complement Inhibition in a Patient with Cryoglobulin-Induced Glomerulonephritis
por: Hirt-Minkowski, Patricia, et al.
Publicado: (2012)

The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients
por: Levenfus, Ian, et al.
Publicado: (2022)

Longitudinal Smartphone-Based Post-hospitalisation Symptom Monitoring in SARS-CoV-2 Associated Respiratory Failure: A Multi-Centre Observational Study
por: Kohlbrenner, Dario, et al.
Publicado: (2021)

Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs
por: Moser, Stephan, et al.
Publicado: (2021)

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases
por: Vogt, Severin, et al.
Publicado: (2020)

Escherichia coli bloodstream infection preceding the diagnosis of rectal carcinoma
por: Thoma, Reto, et al.
Publicado: (2018)

Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency
por: Huber, Xaver, et al.
Publicado: (2017)

Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial
por: Vogt, Severin, et al.
Publicado: (2021)

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial
por: Osthoff, Michael, et al.
Publicado: (2012)

T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
por: Taeschler, Patrick, et al.
Publicado: (2022)

Precision Medicine in the Diagnosis and Management of Orthopedic Biofilm Infections
por: Baldan, Rossella, et al.
Publicado: (2020)

Lysins – a new armamentarium for the treatment of bone and joint infections?
por: Sendi, Parham, et al.
Publicado: (2022)

Critical incidents in a tertiary care clinic for internal medicine
por: Scharein, Paula, et al.
Publicado: (2013)

C1q as a target molecule to treat human disease: What do mouse studies teach us?
por: Schulz, Kristina, et al.
Publicado: (2022)

Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts beyond addressing vaccine inequity
por: Sendi, Parham, et al.
Publicado: (2022)

Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro
por: Rabatscher, Pascal Alexander, et al.
Publicado: (2022)

Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
por: Cervia, Carlo, et al.
Publicado: (2022)

Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19
por: Adamo, Sarah, et al.
Publicado: (2021)

Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
por: Taeschler, Patrick, et al.
Publicado: (2022)

Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients
por: Egli, Adrian, et al.
Publicado: (2013)

A distinct innate immune signature marks progression from mild to severe COVID-19
por: Chevrier, Stéphane, et al.
Publicado: (2020)

Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients
por: Osthoff, Michael, et al.
Publicado: (2011)

Late Spinal Implant Infection caused by Cutibacterium acnes
por: Gisler, Valentin, et al.
Publicado: (2019)

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus
por: Kieninger-Gräfitsch, A., et al.
Publicado: (2020)

Detection of bla(CTX-M) and bla(DHA) genes in stool samples of healthy people: comparison of culture- and shotgun metagenomic-based approaches
por: Campos-Madueno, Edgar I., et al.
Publicado: (2023)

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages
por: Donat, Claudia, et al.
Publicado: (2019)

External Validation of the Modified 4C Deterioration Model and 4C Mortality Score for COVID-19 Patients in a Swiss Tertiary Hospital
por: Wirth, Adriana, et al.
Publicado: (2022)

Are All Joints Equal? Synovial Fluid Analysis in Periprosthetic Joint Infection
por: Sendi, Parham, et al.
Publicado: (2018)

Methylene blue for the diagnosis of a sinus tract in periprosthetic knee joint infection
por: Heinrich, Simon Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cfm4gdic2ubvle3dmgikeibkro